NCT02701465

Brief Summary

The purpose of this randomized clinical trial is two-fold. Firstly to see if patients suffering Subacromial Pain Syndrome can improve blood flow in the supraspinatus muscle in their shoulder, and secondly to investigate how changes in this blood flow are related to pain experience and shoulder function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 8, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

2.2 years

First QC Date

February 25, 2016

Last Update Submit

March 20, 2019

Conditions

Keywords

ShoulderExercise therapy

Outcome Measures

Primary Outcomes (1)

  • Time to exhaustion, incremental test

    participants abduct their shoulder up to 90 degrees in scapula's plane (scapularization) at a frequency of 0,5 Hz. Every minute the load is increased with 250 grams. The test is stopped if participant fails to maintain pace or movement quality, or experiences increased pain. Time at failure is noted as the result.

    Week 0

Secondary Outcomes (14)

  • SPADI questionnaire

    Week 0

  • SPADI questionnaire

    Pre+post-test (8 weeks in-between)

  • Weight

    Week 0

  • Height

    Week 0

  • Age

    Week 0

  • +9 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The subjects in this arm will receive four high intensity (80% of peak work rate) four-minute interval exercises for the abduction movement in the plane of the scapula (m. supraspinatus), supervised three times per week. In addition they will perform the exercise program described for the control group.

Other: Exercise: local high intensity interval exercise

Control group

ACTIVE COMPARATOR

The control group will receive a best clinical practice home-exercise program, with regular follow-ups at the shoulder clinic every other week. The details are described in Granviken et al. (2015).

Other: Exercise: best clinical practice

Interventions

The subjects in this arm will receive four high intensity (80% of peak work rate) four-minute interval exercises for the abduction movement in the plane of the scapula (m. supraspinatus), supervised three times per week. In addition they will perform the exercise program described for the control group.

Intervention group

The control group will receive a best clinical practice home-exercise program, with regular follow-ups at the shoulder clinic every other week. The details are described in Granviken et al. (2015).

Control group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • shoulder pain for longer than three months
  • clinical findings indicative of subacromial pain syndrome (evaluated by Hawkins-Kennedy sign, Neers sign, painful arch and Yokum test)
  • normal passive range of motion of the shoulder

You may not qualify if:

  • subjects unable to provide an informed consent
  • lack of ability to complete the intervention
  • full rupture of the tendon of m. supraspinatus
  • planned shoulder surgery, or previous shoulder surgery on affected shoulder
  • other musculoskeletal problem that could explain the symptoms
  • adhesive capsulitis
  • pregnancy
  • rheumatoid arthritis
  • symptomatic osteoarthritis of the shoulder/shoulder girdle
  • glenohumeral instability
  • widespread pain syndrome
  • unstable underlying heart disease
  • cortisone injections in the shoulder the last month
  • allergies
  • other serious mental or somatic disease (i.e. psychosis or active cancer disease).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Olavs Hospital, back-neck-shoulder multidiciplinary clinic

Trondheim, Norway

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jan Hoff, PhD

    Norwegian University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2016

First Posted

March 8, 2016

Study Start

January 2, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

March 22, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations